Clinical trial
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation
NCT00098735 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00098735 |
|---|---|
| Title | Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation |
| Official title | Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | FTY720 |
| Enrollment | 140 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2006 |
| First posted | Dec 8, 2004 |
| Last update posted | Nov 18, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: